有生育要求子宫内膜异位症和子宫腺肌病患者的保守治疗

摘要/Abstract

摘要：

子宫内膜异位性疾病包括子宫内膜异位症和子宫腺肌病，常合并存在。两者均由具有生长功能的异位子宫内膜所致，但其发病机制不尽相同，临床表现亦有差异。子宫内膜异位性疾病是一种与不孕密切相关的雌激素依赖性疾病，依据临床表现及影像学检查临床可以初步诊断，最终依赖病理确诊。提高妊娠率、缓解疼痛和尽可能地延缓复发是治疗的主要目的。子宫内膜异位性疾病需根据症状、年龄、病变严重程度和生育要求制定个体化的治疗方案。

关键词: 子宫内膜异位症, 子宫腺肌病, 不孕症, 保守治疗

Abstract:

Abstract：Diseases, derived from functional ectopic endometrium, include endometriosis and adenomyosis, which are often merging. Their pathogenesises are not the same and the clinical manifestations have differences. The diseases, with a well-established association with infertility, are estrogen-dependent and could be speculated by clinicians and diagnosed by pathology. The major purposes for treatment include improving pregnancy rates, managing pain and delaying recurrence as far as possible. The optimal method for treatment is an individualized decision that should be made on patient-specific basis, such as symptom, age, staging and the desire of conceive.

Key words: endometriosis, adenomyosis, infertility, conservative treatment

中图分类号:

R711.71

肖喜荣，李斌. 有生育要求子宫内膜异位症和子宫腺肌病患者的保守治疗[J]. 中国实用妇科与产科杂志.

参考文献

[1］ Wood AJJ, Olive D, Pritts EA. Treatment of endometriosis［J］. N Engl Med, 2001, 345(4): 266-275.

[2］ Verkauf BS. Incidence, sumptoms and signs of endometriosis in fertile and infertile women［J］. In J Fla Med Assoc,1987,74(9): 671-675.

[3］ Campo S, Campo V, Benagiano G. Adenomyosis and infertility［J］. Reprod Biomed Online, 2012,24:35-46.

[4］周应芳.子宫内膜异位症的临床诊断和治疗［J］. 中华妇产科杂志, 2005, 40(1): 67-70.

[5］ Berube S, Marcoux S, Langevin M, et al. Fecundity of infertile women with minimal or mild endometriosis and women with unexplained infertility［J］.Fertil Steril, 1998, 69(6): 1034-1041.

[6］ Ozkan S, Murk W, Arici A. Endometriosis-associated Infertility［J］. Ann N Y Acad Sci, 2008, 1127:92-100.

[7］ Practice Comm Amer Soc Reprod. Endometriosis and infertility: a committee opinion［J］. Fertil Steril, 2012, 98(3): 591-598.

[8］ Hughes E, Brown J, Collins JJ, et al. Ovulation suppression for endometriosis for women with subfertility［J］. Cochrane Database Sys Rev,2007(3): CD000155. 

[9］ Kennedy S, Bergqvist A, Chapron C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis［J］. Hum Reprod, 2005, 20(10): 2698-2704.

[10］ Macer ML, Taylor HS. Endometriosis and Infertility a review of the pathogenesis and treatment of endometriosis-associated Infertility［J］. Obstet Gynecol Clin Nor Am, 2012,39(4): 535-549.

[11］ Guzick DS. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis［J］. J Womens Health, 1997, 6: 489-490.

[12］ Abuashim H, EI Rakhawy M, Abd Elaal I. Randomized comparison of superovulation with letrozole vs. clomiphene citrate in an IUI program for women with recently surgically treated minimal to mild endometriosis［J］. Acta Obstet Gynecol Scand, 2012, 91(3): 338-345.

[13］ Dmowski WP, Pry M, Ding J, et al. Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer［J］. Fertil Steril, 2002, 78(4): 750-756.

[14］ Johnson N, Farquhar C, Hadden W, et al. The FLUSH trial-flushing with lipiodol for unexplained (and endometriosis-related) subfertility by hysterosalpingography: a randomized trial［J］. Hum Reprod, 2004, 19(9): 2043-2051.

[15］ Marcoux S, Maheux R, Berube S, et al. Laparoscopic surgery in infertile women with minimal or mild endometriosis［J］. N Engl J Med, 1997,337: 217-222.

[16］ Jacobson TZ, Duffy JM, Barlow D, et al. Laparoscopic surgery for subfertility associated with endometriosis［J］. Cochrane Database Sys Rev, 2010(1): CD001398.

[17］ Furness S, Yap C, Farquhar C, et al. Pre and post-operative medical therapy for endometriosis surgery［J］. Cochrane Database Sys Rev, 2009(1): CD003678.

[18］ Osada H, Silber S, Kakinuma T, et al. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis［J］. Reprod Biomed Online, 2011, 22: 94-99.

[19］ Igarashi M, Abe Y, Fukuda M, et al.Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device［J］. Fertil Steril, 2000, 74: 412-413.

[20］ Kim MD, Kim N, Kim HJ, et al. Pregnancy following uterine artery EM bolization with polyvinyl alcohol particles for patients with uterine fibroid or adenomyosis［J］. Cardiovasc Intervent Radiol, 2005, 28: 611-615.

[1]	彭超, 周应芳. 复发性卵巢子宫内膜异位症的管理[J]. 中国实用妇科与产科杂志, 2022, 38(5): 491-495.
[2]	邓姗, 田秦杰. 子宫内膜息肉与生育[J]. 中国实用妇科与产科杂志, 2022, 38(3): 273-276.
[3]	王绍光, 陈勇华. 子宫肌瘤和子宫腺肌病动脉栓塞治疗手术质量控制[J]. 中国实用妇科与产科杂志, 2022, 38(1): 51-55.
[4]	冷金花，李晓燕. 子宫内膜异位症诊治中有争议的几个问题[J]. 中国实用妇科与产科杂志, 2021, 37(3): 273-276.
[5]	华克勤，易晓芳. 青少年子宫内膜异位症特点和治疗选择[J]. 中国实用妇科与产科杂志, 2021, 37(3): 277-281.
[6]	章婷婷，方小玲. 子宫内膜异位症生育力保护策略[J]. 中国实用妇科与产科杂志, 2021, 37(3): 281-285.
[7]	徐萍，张信美. 卵巢型子宫内膜异位症手术相关问题[J]. 中国实用妇科与产科杂志, 2021, 37(3): 285-287.
[8]	王伟，姚书忠. 输尿管子宫内膜异位症手术相关问题[J]. 中国实用妇科与产科杂志, 2021, 37(3): 287-290.
[9]	郭红燕，刘露. 围绝经期子宫内膜异位症及其恶变问题[J]. 中国实用妇科与产科杂志, 2021, 37(3): 290-292.
[10]	姬苗苗，袁明. 患者教育在子宫内膜异位症长期管理中的重要意义[J]. 中国实用妇科与产科杂志, 2021, 37(3): 292-296.
[11]	袁增，王立杰. 子宫内膜异位症临床诊断和早期治疗相关问题[J]. 中国实用妇科与产科杂志, 2021, 37(3): 296-301.
[12]	戴毅，冷金花. 胸腔子宫内膜异位综合征诊治特点[J]. 中国实用妇科与产科杂志, 2021, 37(3): 301-303.
[13]	彭超，周应芳. 药物治疗在子宫内膜异位症长期管理中的应用和选择[J]. 中国实用妇科与产科杂志, 2021, 37(3): 303-308.
[14]	刘芬婷, 李蓉. 女性生殖道感染对辅助生殖技术妊娠结局的影响#br#[J]. 中国实用妇科与产科杂志, 2021, 37(10): 1007-1012.
[15]	孙莹璞，卜志勤. 重视不孕症的子宫因素及其处理[J]. 中国实用妇科与产科杂志, 2020, 36(6): 481-482.